InMedica Development Corporation - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for InMedica Development Corporation. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

InMedica Development Corporation. The Group's principal activities is to develop and sale of medical technology. It develops and markets portable electrocardiograph (ECG) monitor. Other activity is to research and develop a device to measure hematocrit technology. The hematocrit is the percentage of red blood cells in a given volume of blood. It entered into a Development, Licensing and Manufacturing agreement with Chi Lin pursuant to which InMedica granted Chi Lin a worldwide license to develop and manufacture products based on the hematocrit technology. The Group operates throughout the United States. On 12-Dec-2008, the Group acquired ValuMobile, LLC.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report